MARKET

PPH

PPH

VanEck Pharmaceutical ETF
NASDAQ
86.52
+0.15
+0.17%
Closed 16:00 04/25 EDT
OPEN
86.41
PREV CLOSE
86.37
HIGH
86.82
LOW
86.00
VOLUME
347.61K
TURNOVER
0
52 WEEK HIGH
91.16
52 WEEK LOW
73.26
TOTAL ASSET
495.78M
YTD YIELD
10.44%
1D
5D
1M
3M
1Y
5Y
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
NASDAQ · 1d ago
PPH: Buy The Pullback In This Big Pharma ETF For Long-Term Total Returns
VanEck Pharmaceutical ETF is a popular option for investors looking for exposure to leading pharmaceutical companies. The ETF's top holdings include Eli Lilly, Novo Nordisk, and Johnson & Johnson. The fund has been in an uptrend since late last year and is currently trading at a level that presents a buying opportunity.
Seeking Alpha · 2d ago
Weekly Report: what happened at PPH last week (0415-0419)?
Weekly Report · 3d ago
JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus
NASDAQ · 04/17 14:00
Weekly Report: what happened at PPH last week (0408-0412)?
Weekly Report · 04/15 11:05
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
NASDAQ · 04/15 10:20
Weekly Report: what happened at PPH last week (0401-0405)?
Weekly Report · 04/08 11:11
VanEck Pharmaceutical ETF declares quarterly distribution of $0.5328
Seeking Alpha · 04/03 11:19
More
Profile
Fund Name
VanEck Pharmaceutical ETF
Inception Date
2011-12-20
Benchmark
MVIS US Listed Pharmaceutical 25 NR USD
Advisor Company
Van Eck Associates Corp
Custodian
State Street Bank and Trust Co
Manager
Peter Liao, Guo Hua (Jason) Jin, Griffin Driscoll